The DOI matches its Crossref record; 304 of the 305 references it cites were found in a registry or an index.
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary
Open accessAbstract
This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 report focuses primarily on the revised and novel parts of the document. The most significant changes include: (1) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; (2) for each of the groups A to D, escalation strategies for pharmacologic treatments are proposed; (3) the concept of deescalation of therapy is introduced in the treatment assessment scheme; (4) nonpharmacologic therapies are comprehensively presented; and (5) the importance of comorbid conditions in managing chronic obstructive pulmonary disease is reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The current treatment strategy for COPD includes inhaled corticosteroids, anticholinergics, and β2-agonists, which have been primarily effective in controlling the symptoms but do not cure the underlying disease.184”
From Targeted therapy in chronic diseases using nanomaterial-based drug delivery vehicles (2019) · cites this paper as [184]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Celli, B. R., MacNee, W., Agustí, A. G. N., Anzueto, A. R., Berg, B., Buist, A. S., Calverley, P. M., Chavannes, N. H., Dillard, T. A., Fahy, B. F., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014304 · Cited by 4,405
Self-citationCelli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015
Self-citationSpruit, M. A., Singh, S. J., Garvey, C., ZuWallack, R., Nici, L., Rochester, C., Hill, K., Holland, A. E., Lareau, S. C., Man, W. D.-C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201309-1634st · Cited by 3,938
Self-citationSalmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
CALVERLEY, P. M. A., Anderson, J. A., Celli, B. R., Ferguson, G. T., Jenkins, C. R., Jones, P., Yates, J., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,234
Self-citationJones, P. W., Quirk, F. H., Baveystock, C. M., & Littlejohns, P. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.6.1321 · Cited by 3,035
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
Hurst, J. R., Vestbo, J., Anzueto, A. R., Locantore, N., Müllerová, H., Tal‐Singer, R., Miller, B. E., Lomas, D. A., Agustí, A. G. N., MacNee, W., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909883 · Cited by 2,983
Self-citationBestall, J. C., Paul, E. A., Garrod, R., Garnham, R., Jones, P. W., & Wedzicha, J. A. (1999) · Thorax · doi:10.1136/thx.54.7.581 · Cited by 2,927
Self-citationAntibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
Anthonisen, N. R., MANFREDA, J., WARREN, C. P. W., HERSHFIELD, E. S., HARDING, G. K. M., & NELSON, N. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-2-196 · Cited by 2,474
Buist, A. S., McBurnie, M. A., Vollmer, W. M., Gillespie, S., Burney, P., Mannino, D. M., Menezes, A. M., Sullivan, S. D., Lee, T. A., Weiss, K. B., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61377-4 · Cited by 2,364
Flagged first, then by citations
1 of the 305 references couldn’t be matched to a known paper.
Research works printed but not linked: 34
- Medical Research Council Committee on the Aetiology of Chronic Bronchitis, 1965, Definition and classification of chronic bronchitis for clinical and epidemiological purposes: a report to the Medical Research Council by their Committee on the Aetiology of Chronic Bronchitis, Lancet, 1, 775
- Fletcher, 1960, Standardised questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the Aetiology of Chronic Bronchitis (MRC breathlessness score), BMJ, 2, 1662
- National Institute for Health and Care Excellence, 2016, Multimorbidity: clinical assessment and management, in press
- 1997, Alpha 1-antitrypsin deficiency: memorandum from a WHO meeting, Bull World Health Organ, 75, 397
- van Eerd, 2016, Smoking cessation for people with chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD010744
- van der Meer, 2003, Smoking cessation for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD002999
- McNeill, 2015, E-cigarettes: an evidence update
- McRobbie, 2014, Electronic cigarettes for smoking cessation and reduction, Cochrane Database Syst Rev, 12, CD010216
- Cahill, 2013, Pharmacological interventions for smoking cessation: an overview and network meta-analysis, Cochrane Database Syst Rev, 5, CD009329
- Stead, 2013, Physician advice for smoking cessation, Cochrane Database Syst Rev, 5, CD000165
- Stead, 2016, Combined pharmacotherapy and behavioural interventions for smoking cessation, Cochrane Database Syst Rev, 3, CD008286
- Poole, 2006, Influenza vaccine for patients with chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD002733
- Wongsurakiat, 2003, Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients, J Med Assoc Thai, 86, 497
- Fiore, 2009, Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009, MMWR Recomm Rep, 58, 1
- Appleton, 2006, Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD006101
- Karner, 2014, Tiotropium versus placebo for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 7, CD009285
- Ram, 2002, Oral theophylline for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD003902
- Nannini, 2012, Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 9, CD006829
- Nannini, 2013, Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 8, CD006826
- Yang, 2012, Inhaled corticosteroids for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 7, CD002991
- Chong, 2013, Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 11, CD002309
- Poole, 2015, Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD001287
- Puhan, 2011, Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD005305
- Kruis, 2013, Integrated disease management interventions for patients with chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 10, CD009437
- Halpin, 2009, Palliative and end-of-life care for patients with respiratory diseases, Eur Respir Monograph, 43, 327
- Cranston, 2005, Domiciliary oxygen for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD001744
- Barr, 2005, Inhaled tiotropium for stable chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD002876
- Karner, 2012, Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 4, CD008989
- Tomczyk, 2014, Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Morb Mortal Wkly Rep, 63, 822
- Tiong, 2006, Lung volume reduction surgery for diffuse emphysema, Cochrane Database Syst Rev, CD001001
- Vollenweider, 2012, Antibiotics for exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, 12, CD010257
- Ram, 2006, Antibiotics for exacerbations of chronic obstructive pulmonary disease, Cochrane Database Syst Rev, CD004403
- Schuetz, 2012, Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections, Cochrane Database Syst Rev, CD007498
- Bradley, 1985, Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome, Am Rev Respir Dis, 131, 835
Cited by
Sorted by citations
Items 201–300 of 1,001
Hoffmann, C., Maglakelidze, M., von Schneidemesser, E., Witt, C. C., Hoffmann, P., & Butler, T. M. (2022) · Respiratory Research · doi:10.1186/s12931-022-01983-1 · Cited by 65
Chan, L., Anderson, D. E., Cheng, H. S., Ivan, F. X., Chen, S., Zheng, A. K. E., Foo, R., Gamage, A. M., Tiew, P. Y., Koh, M. S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35253-x · Cited by 72
Quantifying COPD as a risk factor for cardiac disease in a primary prevention cohort
Maclagan, L. C., Croxford, R., Chu, A., Sin, D. D., Udell, J. A., Lee, D. S., Austin, P. C., & Gershon, A. S. (2023) · European Respiratory Journal · doi:10.1183/13993003.02364-2022 · Cited by 65
Self-citationZhang, W., Zhang, Y., Li, C., Jones, P., Wang, C., & Ye, F. (2017) · CHEST Journal · doi:10.1016/j.chest.2017.08.015 · Cited by 65
de, M. M., Menezes, A. M. B., Wehrmeister, F. C., Varela, M. V. L., Casas, A., Ugalde, L., Ramírez‐Venegas, A., I, L. M., López, A. M., Surmont, F., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186777 · Cited by 68
Doxofylline is not just another theophylline!
Matera, M. G., Page, C. P., & Cazzola, M. (2017) · International Journal of COPD · doi:10.2147/copd.s150887 · Cited by 64
Schreiber, J., Sonnenburg, T., & Lücke, E. (2020) · BMC Pulmonary Medicine · doi:10.1186/s12890-020-01246-z · Cited by 64
Zheng, Z., Sun, W., Hu, J., Jie, Z., Xu, J., Cao, J., Song, Y., Wang, C., Wang, J., Zhao, H., et al. (2021) · Respiratory Research · doi:10.1186/s12931-021-01740-w · Cited by 64
Watz, H., Troosters, T., Beeh, K. M., García‐Aymerich, J., Paggiaro, P., Molins, E., Notari, M., Zapata, A., Jarreta, D., & Gil, E. G. (2017) · International Journal of COPD · doi:10.2147/copd.s143488 · Cited by 64
Current approaches to the discovery of novel inhaled medicines
Strong, P., Ito, K., Murray, J., & Rapeport, G. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.05.017 · Cited by 64
Harmonization of Respiratory Data From 9 US Population-Based Cohorts
Oelsner, E. C., Balte, P., Cassano, P. A., Couper, D. J., Enright, P., Folsom, A. R., Hankinson, J., Jacobs, D. R., Kalhan, R., Kaplan, R. C., et al. (2018) · American Journal of Epidemiology · doi:10.1093/aje/kwy139 · Cited by 61
Spirometric changes during exacerbations of COPD: a post hoc analysis of the WISDOM trial
Watz, H., Tetzlaff, K., MAGNUSSEN, H., Mueller, A., Rodriguez‐Roisin, R., Wouters, E. F. �., Vogelmeier, C. F., & Calverley, P. M. A. (2018) · Respiratory Research · doi:10.1186/s12931-018-0944-3 · Cited by 63
Self-citationCanonical WNT pathway is activated in the airway epithelium in chronic obstructive pulmonary disease
Carlier, F. M., Dupasquier, S., Ambroise, J., Detry, B. R., Lecocq, M., Biétry–Claudet, C., Boukala, Y., Gala, J., Bouzin, C., Verleden, S. E., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103034 · Cited by 63
Burtscher, J., Burtscher, M., & Millet, G. P. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101976 · Cited by 67
Zhao, P., Li, J., Tian, Y., Mao, J., Liu, X., 冯素香, Li, J., Bian, Q., Ji, H., & Zhang, L. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.02.023 · Cited by 63
Airway fractal dimension predicts respiratory morbidity and mortality in COPD
Bodduluri, S., Puliyakote, A. S. K., Gerard, S. E., Reinhardt, J. M., Hoffman, E. A., Newell, J. D., Nath, H. P., Han, M. K., Washko, G. R., Estépar, R. S. J., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120693 · Cited by 63
Validation of clinical control in COPD as a new tool for optimizing treatment
Soler‐Cataluña, J. J., Marzo, M., Catalán, P., Miralles, C., Navarrete, B. A., & Miravitlles, M. (2018) · International Journal of COPD · doi:10.2147/copd.s178149 · Cited by 67
Smoking-induced iron dysregulation in the lung
Zhang, W. Z., Butler, J. J., & Cloonan, S. M. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.07.024 · Cited by 62
Kaireit, T. F., Voskrebenzev, A., Gutberlet, M., Freise, J., Jobst, B. J., Kauczor, H., Welte, T., Wacker, F. K., & Vogel‐Claussen, J. (2018) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.26342 · Cited by 62
Lai, C., Chen, C., Lin, C. Y. H., Wang, C., & Wang, Y. (2019) · International Journal of COPD · doi:10.2147/copd.s200846 · Cited by 62
Te, H. S., Perlman, D., Shenoy, C., Steinberger, D. J., Cogswell, R. J., Roukoz, H., Peterson, E. J., Zhang, L., Allen, T. L., & Bhargava, M. (2020) · BMC Pulmonary Medicine · doi:10.1186/s12890-020-01191-x · Cited by 64
Mixed Th2 and non-Th2 inflammatory pattern in the asthma–COPD overlap: a network approach
de Llano, L. A. P., Cosío, B. G., Iglesias, A., Cuevas, N. D. L., Soler‐Cataluña, J. J., Alonso, J. L. I., López-Campos, J. L., Calero, C., Plaza, V., Miravitlles, M., et al. (2018) · International Journal of COPD · doi:10.2147/copd.s153694 · Cited by 62
Tian, B., Widen, S. G., Yang, J., Wood, T. G., Kudlicki, A. S., Zhao, Y., & Brasier, A. R. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.003662 · Cited by 62
Gendron, L. M., Nyberg, A., Saey, D., Maltais, F., & Lacasse, Y. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012290.pub2 · Cited by 69
Predictors of mortality in COPD exacerbation cases presenting to the respiratory intensive care unit
Cao, Y., Xing, Z., Long, H., Huang, Y., Zeng, P., Janssens, J.-P., & Guo, Y. (2021) · Respiratory Research · doi:10.1186/s12931-021-01657-4 · Cited by 61
Baloira, A., Abad, A., Fuster, A., Rivero, J. L. G., García-Sidro, P., Martín, E. M., Palop, M., Soler, N., Velasco, J., & González-Torralba, F. (2021) · International Journal of COPD · doi:10.2147/copd.s297980 · Cited by 63
Du, Y., Ding, Y., Chen, X., Mei, Z., Ding, H., Wu, Y., & Jie, Z. (2017) · Respiratory Research · doi:10.1186/s12931-017-0639-1 · Cited by 61
Natural history of COPD: gaps and opportunities
Agustí, A. G. N., & Celli, B. R. (2017) · ERJ Open Research · doi:10.1183/23120541.00117-2017 · Cited by 64
Self-citationZhang, X., Xiang, S.-Y., Geng, W., Cong, W.-J., Lu, J., Jiang, C., Wang, K., & Liu, Z.-B. (2018) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2018.10.003 · Cited by 62
The Effects of Rare SERPINA1 Variants on Lung Function and Emphysema in SPIROMICS
Ortega, V. E., Li, X., O’Neal, W. K., Lackey, L., Ampleford, E. A., Hawkins, G. A., Grayeski, P. J., Laederach, A., Barjaktarević, I., Barr, R. G., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201904-0769oc · Cited by 59
Parker, M. M., Chase, R., Lamb, A. E., Reyes, A., Saferali, A., Yun, J. H., Himes, B. E., Silverman, E. K., Hersh, C. P., & Castaldi, P. J. (2017) · BMC Medical Genomics · doi:10.1186/s12920-017-0295-9 · Cited by 58
Štambuk, T., Dilber, D., Kifer, D., Selak, N., Keser, T., Ljubičić, Đ., Dugac, A. V., Lauc, G., Rumora, L., & Gornik, O. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1695-0 · Cited by 60
Tang, K., Zhao, J., Xie, J., & Wang, J. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00436.2018 · Cited by 61
Gallic acid protects against the COPD-linked lung inflammation and emphysema in mice
Singla, E., Dharwal, V., & Naura, A. S. (2020) · Inflammation Research · doi:10.1007/s00011-020-01333-1 · Cited by 60
Fan, J., Guo, V. Y., Cao, Z., Cong, S., Wang, N., Lin, H., Wang, C., Bao, H., Lv, X., Wang, B., et al. (2020) · Environment International · doi:10.1016/j.envint.2020.106042 · Cited by 62
Treatable Traits in COPD – A Proposed Approach
Cardoso, J., Ferreira, A. J., Guimarães, M., Oliveira, A. S., Simão, P., & Sucena, M. (2021) · International Journal of COPD · doi:10.2147/copd.s330817 · Cited by 64
Duarte, A. G., Tung, L., Zhang, W., Hsu, E. S., Kuo, Y., & Sharma, G. (2019) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.6.3.2018.0163 · Cited by 59
Evaluation of Dyspnea in the Elderly
Mahler, D. A. (2017) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2017.06.004 · Cited by 59
Jia, J., Conlon, T. M., Sarker, R. S. J., Taşdemir, D., Smirnova, N. F., Srivastava, B., Verleden, S. E., Güneş, G., Wu, X. F., Prehn, C. P., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708349 · Cited by 58
Rodrigo‐Troyano, A., Melo, V., Marcos, P. J., Laserna, E., Peiró, M., Suárez-Cuartín, G., Perea, L., Feliu, A., Plaza, V., Faverio, P., et al. (2018) · Respiration · doi:10.1159/000490190 · Cited by 60
Self-citationBronchiectasis and Chronic Airway Disease
Martínez‐García, M. Á., Polverino, E., & Aksamit, T. R. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.02.024 · Cited by 58
Ye, Z., Ai, X., Liao, Z., You, C., & Cheng, Y. (2019) · Medicine · doi:10.1097/md.0000000000016371 · Cited by 57
Heme scavenging reduces pulmonary endoplasmic reticulum stress, fibrosis, and emphysema
Aggarwal, S., Ahmad, I., Lam, A., Carlisle, M. A., Li, C., Wells, J. M., Raju, S. V., Athar, M., Rowe, S. M., Dransfield, M. T., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.120694 · Cited by 54
Westcott, A. R., Capaldi, D. P. I., McCormack, D. G., Ward, A. D., Fenster, A., & Párraga, G. (2019) · Radiology · doi:10.1148/radiol.2019190450 · Cited by 57
Sang, L., Zhao, Z., Yun, P.-J., Frerichs, I., Möller, K., Fu, F., Liu, X., Zhong, N., & Li, Y. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-4182 · Cited by 57
Yang, C.-Y., Li, S.-W., Chin, C.-Y., Hsu, C., Lee, C., Yeh, Y., & Wu, K.-A. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02788-4 · Cited by 60
Dysanapsis as a Determinant of Lung Function in Development and Disease
McGinn, E. A., Mandell, E. W., Smith, B. J., Duke, J. W., Bush, A., & Abman, S. H. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202306-1120pp · Cited by 62
Recent advances in understanding lung function development
Melén, E., & Guerra, S. (2017) · F1000Research · doi:10.12688/f1000research.11185.1 · Cited by 57
Frailty assessment in older adults with chronic obstructive respiratory diseases
Guan, C., & Niu, H. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s173239 · Cited by 59
Life-Space mobility and clinical outcomes in COPD
Iyer, A. S., Wells, J. M., Bhatt, S. P., Kirkpatrick, D., Sawyer, P., Brown, C. J., Allman, R. M., Bakitas, M. A., & Dransfield, M. T. (2018) · International Journal of COPD · doi:10.2147/copd.s170887 · Cited by 57
Huang, C., Liu, Y., & Shi, G. (2020) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-1027-z · Cited by 83
Quantitative CT detects progression in COPD patients with severe emphysema in a 3-month interval
Konietzke, P., Wielpütz, M. O., Wagner, W. L., Wuennemann, F., Kauczor, H., Heußel, C. P., Eichinger, M., Eberhardt, R., Gompelmann, D., & Weinheimer, O. (2020) · European Radiology · doi:10.1007/s00330-019-06577-y · Cited by 57
Checa, J., & Aran, J. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239317 · Cited by 55
Luo, J., Zhang, D., Tang, W., Dou, L., & Sun, Y. (2021) · Clinical Interventions in Aging · doi:10.2147/cia.s303852 · Cited by 56
Sex Hormones and Lung Inflammation
Reyes-García, J., Montaño, L. M., Carbajal-García, A., & Wang, Y.-X. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-68748-9_15 · Cited by 60
Sensitization to Aspergillus fumigatus as a risk factor for bronchiectasis in COPD
Everaerts, S., Lagrou, K., Dubbeldam, A., Lorent, N., Vermeersch, K., Hoeyveld, E. V., Bossuyt, X., Dupont, L., Vanaudenaerde, B. M., & Janssens, W. (2017) · International Journal of COPD · doi:10.2147/copd.s141695 · Cited by 56
Chronic Obstructive Pulmonary Disease and Stroke
Corlăteanu, A., Covanţev, S., Mathioudakis, A. G., Botnaru, V., Cazzola, M., & Siafakas, N. M. (2018) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2018.1464551 · Cited by 56
Diago, C. A. A., García‐Unzueta, M. T., Lavín, B. A., Guerra-Ruiz, A. R., Calvo, J. A., Ramos, L., & Muñoz, P. (2018) · Respiration · doi:10.1159/000494296 · Cited by 57
p53 in Bronchial Club Cells Facilitates Chronic Lung Inflammation by Promoting Senescence
Sagiv, A., Bar-Shai, A., Levi, N., Hatzav, M., Zada, L., Ovadya, Y., Roitman, L., Manella, G., Regev, O., Majewska, J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.009 · Cited by 55
Lasithiotaki, I., Tsitoura, E., Samara, K. D., Trachalaki, A., Charalambous, I., Tzanakis, Ν., & Antoniou, K. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205242 · Cited by 57
Absolute lung size and the sex difference in breathlessness in the general population
Ekström, M. P., Sundh, J., Schiöler, L., Lindberg, E., Rosengren, A., Bergström, G. M. L., Angerås, O., Hedner, J. A., Brandberg, J., Bake, B., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190876 · Cited by 55
Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD
Filho, F. S. L., Won, S. H., Mattman, A., Schellenberg, R. S., Criner, G. J., Woodruff, P. G., Lazarus, S. C., Albert, R. K., Connett, J. E., Han, M. K., et al. (2018) · Respiratory Research · doi:10.1186/s12931-018-0733-z · Cited by 55
Self-citationCOPD stands for complex obstructive pulmonary disease
Houben‐Wilke, S., Augustin, I. M. L., Vercoulen, J. H., van Ranst, D., de Vaate, E. B., Wempe, J. B., Spruit, M. A., Wouters, E. F. �., & Franssen, F. M. E. (2018) · European Respiratory Review · doi:10.1183/16000617.0027-2018 · Cited by 59
Cheng, S.-L. (2018) · International Journal of COPD · doi:10.2147/copd.s175017 · Cited by 55
Emphysema: looking beyond alpha-1 antitrypsin deficiency
Janssen, R., Piscaer, I., Franssen, F. M. E., & Wouters, E. F. �. (2019) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2019.1580575 · Cited by 59
Xia, H., Xue, J., Xu, H., Lin, M., Shi, M., Sun, Q., Xiao, T., Dai, X., Wu, L. Y., Li, J., et al. (2019) · Toxicology · doi:10.1016/j.tox.2019.05.009 · Cited by 55
Aridgides, D. S., Mellinger, D., Armstrong, D. A., Hazlett, H. F., Dessaint, J. A., Hampton, T. H., Atkins, G. T., Carroll, J. L., & Ashare, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-46045-7 · Cited by 58
Halpin, D. M. G., de Jong, H. J. I., Carter, V. A., Skinner, D., & Price, D. B. (2019) · EClinicalMedicine · doi:10.1016/j.eclinm.2019.07.003 · Cited by 55
Self-citationZinellu, E., Fois, A. G., Sotgiu, E., Mellino, S., Mangoni, A. A., Carru, C., Zinellu, A., & Pirina, P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10020269 · Cited by 54
Sriram, K. B., Cox, A. J., Clancy, R. L., Slack, M., & Cripps, A. W. (2017) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2017.1329274 · Cited by 58
Kahnert, K., Alter, P. J., Welte, T., Huber, R. M., Behr, J., Biertz, F., Watz, H., Bals, R., Vogelmeier, C. F., & Jörres, R. A. (2018) · Respiratory Research · doi:10.1186/s12931-018-0815-y · Cited by 54
Self-citationSlebos, D., ten Hacken, N. H. T., Hetzel, M., Herth, F. J. F., & Shah, P. L. (2018) · Respiration · doi:10.1159/000490193 · Cited by 54
Kaddouri, B. E., Strand, M. J., Baraghoshi, D., Humphries, S. M., Charbonnier, J., van Rikxoort, E. M., & Lynch, D. A. (2020) · Radiology · doi:10.1148/radiol.2020200563 · Cited by 53
Lung microbiome and cytokine profiles in different disease states of COPD: a cohort study
Xue, Q., Xie, Y., He, Y., Yu, Y., Fang, G., Yu, W., Wu, J., Li, J., Zhao, L., Deng, X., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-32901-0 · Cited by 53
Smid, D. E., Franssen, F. M. E., Gonik, M. M., Miravitlles, M., Casanova, C., Cosío, B. G., de Lucas‐Ramos, P., Marín, J. M., González, C. M., Mir, I., et al. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.09.003 · Cited by 53
Self-citationAlter, P. J., Watz, H., Kahnert, K., Pfeifer, M. A., Randerath, W. J., Andreas, S., Waschki, B., Kleibrink, B. E., Welte, T., Bals, R., et al. (2018) · Respiratory Medicine · doi:10.1016/j.rmed.2018.02.011 · Cited by 53
Self-citationDima, E., Kyriakoudi, A., Kaponi, M., Vasileiadis, I., Stamou, P., Koutsoukou, A., Koulouris, N. G., & Rovina, N. (2019) · Respiratory Medicine · doi:10.1016/j.rmed.2019.08.012 · Cited by 53
Janjua, S., Pike, K. C., Carr, R., Coles, A., Normansell, R., & Batavia, M. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013381.pub2 · Cited by 52
Wang, L. H., Zhao, Y., Chen, L. Y., Zhang, L., & Zhang, Y. M. (2019) · The Clinical Respiratory Journal · doi:10.1111/crj.13112 · Cited by 53
Tan, L., Tang, X., Pan, C., Wang, H., & Pan, Y. (2019) · Journal of Periodontology · doi:10.1002/jper.17-0705 · Cited by 52
Puchakayala, P. R. A., Sthanam, V. L., Nakhmani, A., Chaudhary, M. F. A., Puliyakote, A. S. K., Reinhardt, J. M., Zhang, C., Bhatt, S. P., & Bodduluri, S. (2023) · Radiology · doi:10.1148/radiol.222998 · Cited by 52
Huang, J., Li, W., Sun, Y., Huang, Z., Cong, R., Chen, Y., & Tao, H. (2024) · International Journal of COPD · doi:10.2147/copd.s453086 · Cited by 56
The revised GOLD 2017 COPD categorization in relation to comorbidities
Kahnert, K., Alter, P. J., Young, D., Lucke, T., Heinrich, J., Huber, R. M., Behr, J., Wacker, M. E., Biertz, F., Watz, H., et al. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.12.003 · Cited by 52
Self-citationChapman, K. R., Chorostowska‐Wynimko, J., Koczulla, A., Ferrarotti, I., & McElvaney, N. G. (2018) · International Journal of COPD · doi:10.2147/copd.s149429 · Cited by 52
Abdallah, S. J., Smith, B. M., Ware, M. A., Moore, M., Li, P. Z., Bourbeau, J., & Jensen, D. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201803-198oc · Cited by 52
Self-citationFranssen, F. M. E., Smid, D. E., Deeg, D. J. H., Huisman, M. A., Poppelaars, J. L., Wouters, E. F. �., & Spruit, M. A. (2018) · npj Primary Care Respiratory Medicine · doi:10.1038/s41533-018-0097-3 · Cited by 52
Alter, P. J., Mayerhofer, B., Kahnert, K., Watz, H., Waschki, B., Andreas, S., Biertz, F., Bals, R., Vogelmeier, C. F., & Jörres, R. A. (2019) · International Journal of COPD · doi:10.2147/copd.s209343 · Cited by 52
Self-citationMa, R., Yin, Y., Wang, Y., Liu, X., & Xie, J. (2019) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2019.101071 · Cited by 56
Sputum and salivary protein biomarkers and point-of-care biosensors for the management of COPD.
Dong, T., Santos, S., Yang, Z.-C., Yang, S., & Kirkhus, N. E. (2020) · In Analysis · doi:10.1039/c9an01704f · Cited by 36
Extracellular vesicles in chronic obstructive pulmonary disease (COPD)
O’Farrell, H. E., & Yang, I. A. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.10.16 · Cited by 51
Wang, M., Lin, E. P.-Y., Huang, L., Li, C., Shyr, Y., & Lai, C. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.02.046 · Cited by 51
Predictors of Asthma/COPD Overlap in FDNY Firefighters With World Trade Center Dust Exposure
Singh, A., Liu, C., Putman, B., Zeig‐Owens, R., Hall, C. B., Schwartz, T. M., Webber, M. P., Cohen, H. W., Berger, K. I., Nolan, A., et al. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.07.002 · Cited by 51
Ma, J., Zheng, J., Zhong, N., Bai, C., Wang, H., Du, J., Li, F., Chen, Y., Shi, Z., Li, X., et al. (2018) · International Journal of COPD · doi:10.2147/copd.s170555 · Cited by 51
Koo, H. J., Lee, S. M., Seo, J. B., Lee, S. M., Kim, N., Oh, S. Y., Lee, J., & Oh, Y. (2019) · Korean Journal of Radiology · doi:10.3348/kjr.2018.0391 · Cited by 51
Guo, H., Su, Y., & Deng, F. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10085-8 · Cited by 51
Remy, K. E., Verhoef, P. A., Malone, J. R., Ruppe, M. D., Kaselitz, T. B., Lodeserto, F., Hirshberg, E. L., Slonim, A. D., & Dezfulian, C. (2020) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000002429 · Cited by 49
Genome-Wide Gene-by-Smoking Interaction Study of Chronic Obstructive Pulmonary Disease
Kim, W., Prokopenko, D., Sakornsakolpat, P., Hobbs, B. D., Lutz, S. M., Hokanson, J. E., Wain, L. V., Melbourne, C., Shrine, N. R. G., Tobin, M. D., et al. (2020) · American Journal of Epidemiology · doi:10.1093/aje/kwaa227 · Cited by 50
de Vries, R., Farzan, N., Fabius, T. M., de Jongh, F. H., Jak, P. M. C., Haarman, E. G., Snoey, E., Veen, J. C. C. M. I. ’., Dagelet, Y. W. F., der Zee, A. H. M., et al. (2023) · CHEST Journal · doi:10.1016/j.chest.2023.04.050 · Cited by 50
Thomas, R. M., Locke, E. R., Woo, D. M., Nguyen, E. H. K., Press, V. G., Layouni, T. A., Trittschuh, E. H., Reiber, G. E., & Fan, V. S. (2017) · Respiratory Care · doi:10.4187/respcare.05445 · Cited by 51
Lim, S. Y., Lim, G., Lee, Y. J., Cho, Y., Park, J. S., Yoon, H. I., Lee, J. H., & Lee, C. (2019) · International Journal of COPD · doi:10.2147/copd.s214716 · Cited by 50
Metadata
- Authors
- Vogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., Frith, P., Halpin, D. M. G., López Varela, M. V., Nishimura, M., Roche, N., Rodriguez-Roisin, R., Sin, D. D., Singh, D., Stockley, R., Vestbo, J., Wedzicha, J. A., & Agustí, A.
- Affiliations
- Philipps University of Marburg (DE)
- Temple University (US)
- New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, New York
- The University of Texas at San Antonio Health Science Center (US)
- Imperial College London (GB)
- McGill University Health Centre (CA)
- Brigham and Women’s Hospital, Boston, Massachusetts
- First Affiliated Hospital of Guangzhou Medical University (CN)
- KU Leuven (BE)
- University of Modena and Reggio Emilia (IT)
- Flinders University (AU)
- Royal Devon and Exeter Hospital (GB)
- Universidad de la República, Hospital Maciel, Montevideo, Uruguay
- Hokkaido University (JP)
- Hôpital Cochin (Assistance Publique–Hôpitaux de Paris), University Paris Descartes, Paris, France
- Thorax Institute, Hospital Clinic Universitat de Barcelona, Barcelona, Spain
- University of British Columbia (CA)
- University Hospital, Birmingham, United Kingdom; and
- University of Manchester (GB)
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
- Corresponding author
- Vogelmeier, Claus F.
- ORCID
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-03-01
- Volume
- 195
- Issue
- 5
- Pages
- 557-582
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2583265473
- Cited by
- 3,187
- References
- 305
- Citations by year
- 2026: 118 · 2025: 162 · 2024: 247 · 2023: 307 · 2022: 415 · 2021: 441 · 2020: 449 · 2019: 436 · 2018: 428 · 2017: 173
- FWCI
- 336.54
- Type
- journal article
- Language
- en
- Open access
- green
- lirias.kuleuven.be
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Lirias (KU Leuven) (submittedVersion, other-oa)
- Royal Devon and Exeter Research Repository (Royal Devon and Exeter) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0510-10270, NF-SI-0513-10077, NF-SI-0611-10148)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- chronic obstructive pulmonary disease, GOLD 2017, COPD diagnosis, COPD management, COPD prevention, exacerbations, non-pharmacological treatment, comorbidities, spirometry, symptom assessment
- MeSH terms
- Bronchodilator Agents, Humans, Risk Factors, Spirometry, Global Health, Pulmonary Disease, Chronic Obstructive, Internationality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
